Literature DB >> 17592576

Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C.

Veysel Tahan, Gulgun Tahan, Faysal Dane, Suleyman Uraz, Mithat Yardim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592576

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


× No keyword cloud information.
  5 in total

1.  First report of telaprevir-induced pancreatitis.

Authors:  Carlos Ventura; Ryan Urich; Shannon Skinner; Robert Bina; Keng-Yu Chuang; David H Van Thiel; Abdul Nadir
Journal:  Dig Dis Sci       Date:  2013-02-08       Impact factor: 3.199

2.  Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load.

Authors:  Kenji Ando; Soo Ryang Kim; Susumu Imoto; Taisuke Nakajima; Keiji Mita; Katsumi Fukuda; Miyuki Taniguchi; Noriko Sasase; Akira Muramatsu; Toshiyuki Matsuoka; Masatoshi Kudo; Yoshitake Hayashi
Journal:  Case Rep Gastroenterol       Date:  2009-11-21

Review 3.  Drug-induced pancreatitis : incidence, management and prevention.

Authors:  Anil R Balani; James H Grendell
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

5.  Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C.

Authors:  Jong Wook Choi; June Sung Lee; Woo Hyun Paik; Tae Jun Song; Jung Wook Kim; Won Ki Bae; Kyung-Ah Kim; Jung Gon Kim
Journal:  Clin Mol Hepatol       Date:  2016-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.